Literature DB >> 33091411

Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome.

William D Chey1, Laurie Keefer2, Kevin Whelan3, Peter R Gibson4.   

Abstract

Irritable bowel syndrome (IBS) is a common, symptom-based condition that has negative effects on quality of life and costs health care systems billions of dollars each year. Until recently, management of IBS has focused on over-the-counter and prescription medications that reduce symptoms in fewer than one-half of patients. Patients have increasingly sought natural solutions for their IBS symptoms. However, behavioral techniques and dietary modifications can be effective in treatment of IBS. Behavioral interventions include gastrointestinal-focused cognitive behavioral therapy and gut-directed hypnotherapy to modify interactions between the gut and the brain. In this pathway, benign sensations from the gut induce maladaptive cognitive or affective processes that amplify symptom perception. Symptoms occur in response to cognitive and affective factors that trigger fear of symptoms or lack of acceptance of disease, or from stressors in the external environment. Among the many dietary interventions used to treat patients with IBS, a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols is the most commonly recommended by health care providers and has the most evidence for efficacy. Patient with IBS who choose to follow a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols should be aware of its 3 phases: restriction, reintroduction, and personalization. Management of IBS should include an integrated care model in which behavioral interventions, dietary modification, and medications are considered as equal partners. This approach offers the greatest likelihood for success in management of patients with IBS.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARFID; Cognitive Behavioral Therapy; FODMAPs; Hypnosis

Mesh:

Year:  2020        PMID: 33091411     DOI: 10.1053/j.gastro.2020.06.099

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  Dietary management of adults with IBD - the emerging role of dietary therapy.

Authors:  Jessica A Fitzpatrick; Sarah L Melton; Chu Kion Yao; Peter R Gibson; Emma P Halmos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-16       Impact factor: 73.082

Review 2.  How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.

Authors:  Nessmah Sultan; Jane E Varney; Emma P Halmos; Jessica R Biesiekierski; Chu K Yao; Jane G Muir; Peter R Gibson; Caroline J Tuck
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 3.  Irritable bowel syndrome in midlife women: a narrative review.

Authors:  Pei-Lin Yang; Margaret M Heitkemper; Kendra J Kamp
Journal:  Womens Midlife Health       Date:  2021-05-31

Review 4.  Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.

Authors:  Abhilash Perisetti; Hemant Goyal
Journal:  Dig Dis Sci       Date:  2021-03-03       Impact factor: 3.199

Review 5.  Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation.

Authors:  Sarah Patel; Bethany Doerfler; Katerine Boutros; Samson Ng; Machelle Manuel; Elayne DeSimone
Journal:  Int J Gen Med       Date:  2021-04-21

6.  Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.

Authors:  Elise Nordin; Carl Brunius; Rikard Landberg; Per M Hellström
Journal:  Am J Clin Nutr       Date:  2022-02-09       Impact factor: 7.045

7.  Limited Access to Integral Care: Digital Therapeutics Show Promise of Scalable Solutions to Behavioral Interventions.

Authors:  Megan E Riehl
Journal:  Clin Transl Gastroenterol       Date:  2022-01-11       Impact factor: 4.396

8.  Psychological Considerations in the Dietary Management of Patients With DGBI.

Authors:  Helen Burton Murray; Bethany Doerfler; Kimberly N Harer; Laurie Keefer
Journal:  Am J Gastroenterol       Date:  2022-04-08       Impact factor: 12.045

9.  The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.

Authors:  Hithin Noble; Syed Shariq Hasan; Peter J Whorwell; Dipesh H Vasant
Journal:  Neurogastroenterol Motil       Date:  2022-03-03       Impact factor: 3.960

10.  Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis.

Authors:  Tiffany H Taft; Dustin A Carlson; Madison Simons; Sonia Zavala; Ikuo Hirano; Nirmala Gonsalves; John E Pandolfino
Journal:  Gastroenterology       Date:  2021-06-19       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.